Avience Biomedicals Limited
ListedSMEHealthcare · NSE
Incorporated in June 2024, Avience Biomedicals Limited is an ISO-certified company engaged in the manufacturing, supply, and export of molecular diagnostic solutions for the biotechnology, genomics, and in-vitro diagnostics (IVD) sectors. The company offers a wide range of healthcare products, including rapid test kits, molecular diagnostic kits, biochemistry and hematology analyzers, medical devices, and diagnostic reagents. Its products serve pathology laboratories, hospitals, microbiology labs, and research centers in India and overseas. Along with manufacturing, the company also operates as a distributor and trader of medical equipment. Its manufacturing facility is located in Noida, Uttar Pradesh. As of January 31, 2026, Avience Biomedicals had 75 permanent employees and 33 contractual employees.
Price Band
₹196 – ₹208
Issue Size
₹145.38 L Cr
Lot Size
600 shares
GMP
₹110
+52.9%
Est. Listing
₹318
at current GMP
Subscribed
385.40x
overall
Open
18 Jun 2026
Close
22 Jun 2026
Allotment
23 Jun 2026
Refund
24 Jun 2026
Demat Credit
25 Jun 2026
Listing
25 Jun 2026
Last updated 3 months ago
Official Registrar Verification
Avience Biomedicals Limited Allotment Status
Designated Registrar: Skyline Financial Services Private Limited
Allotment Date
23 Jun 2026
Basis finalization
Refunds Initiate
24 Jun 2026
Mandate release
Demat Credit
25 Jun 2026
Shares in demat
Listing Debut
25 Jun 2026
Trading begins
How to Check Avience Biomedicals Limited IPO Allotment Status
- Click the Check on Registrar button above to visit Skyline Financial Services Private Limited's allotment portal.
- Select Avience Biomedicals Limited from the dropdown company list.
- Choose your lookup mode: PAN Number, Application Number, or DP Client ID.
- Enter your details accurately and solve the Captcha code.
- Click Submit / Search to view the number of shares applied and allotted to you.
About Avience Biomedicals Limited Public Issue & Market Profile
Avience Biomedicals Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹14,53,800 Crores. The shares are offered at a price band of ₹196 to ₹208 per equity share on NSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Public Issue & Allotment Procedure:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 600 shares (approx. ₹1,24,800 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Official Allotment Timelines & Registrar Guidance:
Allotment reconciliation will be managed by Skyline Financial Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2026-06-25, while un-allotted funds or UPI block mandates will be released on 2026-06-24.
Frequently Asked Questions
What if my name is not showing on the registrar portal?
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
How will I receive the refund if I don't get allotment?
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.